Search - tctmd.com

Displaying 201 - 220 of 555

Sort: Relevancy | Date

Presentation TCT 2018

First-In-Man Testing of a Dedicated Closure Device for Trans-Caval Access for Transcatheter Aortic Valve Replacement (Transmural Systems)

Presenter: Toby Rogers

September 21, 2018

Presentation TCT 2018

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

Presenter: David Hildick-Smith, Martin B. Leon, Andrejs Erglis

September 21, 2018

Presentation TCT 2018

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

Presenter: David Hildick-Smith, Martin B. Leon, Andrejs Erglis

September 21, 2018

Presentation TCT 2018

Real-Time Bleed Detection and Monitoring: Initial Clinical Experience with the Early Bird Bleed Monitoring System (Saranas)

Presenter: Philippe Genereux

September 21, 2018

Presentation TCT 2018

TCT-54: The Distribution of High-Risk Plaques with Respect to Artery Stenosis in Non-Culprit Non-Ischemic Native Coronary Lesions of Diabetic Patients data from COMBINE OCT-FFR study

Presenter: John A. Ambrose, Farouc A Jaffer, Tomasz Roleder

September 21, 2018

Presentation TCT 2018

TCT-42: An Early Feasibility Study to Assess Safety and Effectiveness of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)

Presenter: David Hildick-Smith, Martin B. Leon, Hendrik Treede

September 21, 2018

Presentation TCT 2018

Transcatheter Polymeric Pulmonary Valve for Congenital Heart Disease Applications (PolyVascular)

Presenter: Henri Justino

September 21, 2018

Presentation TCT 2018

Endogenous Leaflet Restoration Technology (Xeltis) Status Update for Aortic Valve Replacement Therapy

Presenter: Christian M. Spaulding

September 21, 2018

Presentation TCT 2018

TCT-41: Acute and Six-month Outcomes of a Novel Self-Expanding Transcatheter Heart Valve

Presenter: David Hildick-Smith, Martin B. Leon, Ulrich Schäfer

September 21, 2018

Presentation TCT 2018

Early Experiences with the New TriGUARD 3 Embolic Protection Device During TAVR: The REFLECT Trial

Presenter: Tamim Nazif

September 21, 2018

Presentation TCT 2018

Full Body Embolic Protection During TAVR (Filterlex)

Presenter: Giora Weisz

September 21, 2018

Presentation TCT 2018

TCT-16: Incidence, Outcomes, And Microbiologic Profile Of Prosthetic Valve Endocarditis After TAVR And SAVR: Insights From PARTNER

Presenter: Charles J. Davidson, Jeffrey J. Popma, Matthew Summers

September 21, 2018

Presentation TCT 2018

Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction During Transcatheter Aortic Valve Replacement: A Prospective IDE Trial (BASILICA)

Presenter: Jaffar M Khan

September 21, 2018

Presentation TCT 2018

TCT-19: Predicting TMVR-Related LVOT Obstruction: Concept of Fluid Mechanics Modeling

Presenter: Eric Eeckhout, Glenn Van Langenhove, Keshav Kohli

September 21, 2018

Presentation TCT 2018

TCT-15: Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanically- versus Self-Expandable Valves: Results From The REPRISE III Randomized Trial

Presenter: Charles J. Davidson, Jeffrey J. Popma, Michael J. Reardon

September 21, 2018

Presentation TCT 2018

Featured Lecture: Future Innovation in TAVR: Remaining Clinical Needs, Novel Technologies and Ancillary Device Strategies

Presenter: Dariusz Dudek, Ran Kornowski, Axel Linke, Martin B. Leon

September 21, 2018

Presentation TCT 2018

TCT-14: Final 5-Year Outcomes Of The REPRISE II Study: Long-Term Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve

Presenter: Charles J. Davidson, Jeffrey J. Popma, Nicolas Dumontiel

September 21, 2018

Presentation TCT 2018

Update of the NeoVas BRS Clinical Trials

Presenter: Runlin Gao, Martin B. Leon, Yaling Han

September 21, 2018

Presentation TCT 2018

New TAVR Devices: VitaFlow, Venus A Plus, and Venibri

Presenter: Runlin Gao, Martin B. Leon, Junbo Ge

September 21, 2018

Presentation TCT 2018

Debate Con: TAVR for Moderate-Risk Patients: SAVR Remains First Line of Therapy!

Presenter: Jose Armando Mangione

September 21, 2018

Advertisement

First-In-Man Testing of a Dedicated Closure Device for Trans-Caval Access for Transcatheter Aortic Valve Replacement (Transmural Systems)

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

Real-Time Bleed Detection and Monitoring: Initial Clinical Experience with the Early Bird Bleed Monitoring System (Saranas)

TCT-54: The Distribution of High-Risk Plaques with Respect to Artery Stenosis in Non-Culprit Non-Ischemic Native Coronary Lesions of Diabetic Patients data from COMBINE OCT-FFR study

TCT-42: An Early Feasibility Study to Assess Safety and Effectiveness of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)

Transcatheter Polymeric Pulmonary Valve for Congenital Heart Disease Applications (PolyVascular)

Endogenous Leaflet Restoration Technology (Xeltis) Status Update for Aortic Valve Replacement Therapy

TCT-41: Acute and Six-month Outcomes of a Novel Self-Expanding Transcatheter Heart Valve

Early Experiences with the New TriGUARD 3 Embolic Protection Device During TAVR: The REFLECT Trial

Full Body Embolic Protection During TAVR (Filterlex)

TCT-16: Incidence, Outcomes, And Microbiologic Profile Of Prosthetic Valve Endocarditis After TAVR And SAVR: Insights From PARTNER

Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction During Transcatheter Aortic Valve Replacement: A Prospective IDE Trial (BASILICA)

TCT-19: Predicting TMVR-Related LVOT Obstruction: Concept of Fluid Mechanics Modeling

TCT-15: Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanically- versus Self-Expandable Valves: Results From The REPRISE III Randomized Trial

Featured Lecture: Future Innovation in TAVR: Remaining Clinical Needs, Novel Technologies and Ancillary Device Strategies

TCT-14: Final 5-Year Outcomes Of The REPRISE II Study: Long-Term Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve

Update of the NeoVas BRS Clinical Trials

New TAVR Devices: VitaFlow, Venus A Plus, and Venibri

Debate Con: TAVR for Moderate-Risk Patients: SAVR Remains First Line of Therapy!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content